A randomized clinical trial shows combined treatment is non-inferior to prolonged corticosteroids in bullous pemphigoid, indicating potential benefits and risks.
Maintenance therapy with low-dose MTX is non-inferior to prolonged STS in terms of survival and is associated with a reduced risk of relapse, at the cost of increased toxicity.
No takes yet. Share an insight, caveat, or question.
Dereure et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: